Pharmalot… Pharmalittle… G’Morning, Everyone
Make a commentBy Ed Silverman // November 25th, 2008 // 6:48 am
A bit dreary here in the nation’s medicine chest as we awake to gray skies and a slight drizzle. Still, our spirits are high. And despite the looming holiday here in the US, there is much to do. So time to get started. Here are a few items to help you along. Hope your day is meaningful…
AstraZeneca, Abraxis To End Cancer Drug Trial (Reuters)
Lilly Outsources Clinical-Data Management (PharmaTimes)
Roche Agrees To Pay $50M For Memory Pharma (The Star-Ledger)
Crestor Scrips Rise After Jupiter Study (Reuters)
Schering-Plough Sees 5 NDAs In 2009 (Dow Jones)
FDA Panel OKs New Gout Drug (WebMD)
Avandia Riskier Than Actos For Older Diabetics (Philly.com)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Abraxis Pharmaceuticals, Actos, AstraZeneca, Avandia, Crestor, GlaxoSmithKline, Gout, Schering Plough, Takeda Pharmaceutical